David L. Grange, Chief Executive Officer at PHARMACEUTICAL PRODUCT DEVELOPMENT INC (PPDI), sold 34,501 shares at $26.00 ($897K) on 2011-02-28, disclosed to the SEC on 2011-03-01.
Open-market sale of $897k PPDI by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| PPDI | SELL | 2007-07-27 | $184K | — | Filing → |
| PPDI | SELL | 2007-02-12 | $205K | — | Filing → |
| PPDI | SELL | 2006-05-24 | $362K | — | Filing → |